1.
First-in-human randomised trial and follow-up study of Plasmodium falciparum blood-stage malaria vaccine BK-SE36 with CpG-ODN(K3)
by Ezoe, Sachiko
Vaccine, 2020, Vol.38 (46), p.7246-7257
2.
Development of vaccines for Plasmodium vivax malaria
by Mueller, Ivo
Vaccine, 2015, Vol.33 (52), p.7489-7495
3.
4.
Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite
by Friesen, Johannes
Vaccine, 2011, Vol.29 (40), p.7002-7008
5.
Quantification of human complement factor H binding to asexual malaria blood stages by an enzyme-linked immunosorbent assay
by Simon, Nina
Vaccine, 2018, Vol.36 (12), p.1545-1547
6.
7.
8.
9.
Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan
by Iriemenam, Nnaemeka C
Vaccine, 2008, Vol.27 (1), p.62-71
10.
The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine
by Hui, George
Vaccine, 2007, Vol.25 (51), p.8549-8556
11.
Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya
by Agak, George W
Vaccine, 2008, Vol.26 (16), p.1963-1971
12.
Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein
by Yazdani, Syed Shams
Vaccine, 2004, Vol.22 (27), p.3727-3737
13.
14.
High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules
by Benmohamed, Lbachir
Vaccine, 2000, Vol.18 (25), p.2843-2855
15.
Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein
by Urquiza, Mauricio
Vaccine, 2000, Vol.19 (4), p.508-513
16.
Induction and displacement of an helix in the 6725 SERA peptide analogue confers protection against P. falciparum malaria
by Alba, Martha Patricia
Vaccine, 2004, Vol.22 (9-10), p.1281-1289
17.
A novel adjuvant for use with a blood-stage malaria vaccine
by de Souza, J.B
Vaccine, 1995, Vol.13 (14), p.1316-1319
18.
19.
Establishment of a SCID mouse model having circulating human red blood cells and a possible growth of Plasmodium falciparum in the mouse
by Tsuji, Masayoshi
Vaccine, 1995, Vol.13 (15), p.1389-1392
20.
Transmission blocking malaria vaccines: Assays and candidates in clinical development
by Sauerwein, R.W
Vaccine, 2015, Vol.33 (52), p.7476-7482
